Evidence map›Paper›PMID 38064488›Full record

ArticleCannabis and cannabinoid research2024

Pharmacological Characterization of the Endocannabinoid Sensor GRAB

Simar Singh, Dennis Sarroza, Anthony English, Maya McGrory, Ao Dong, Larry Zweifel, Benjamin B Land, Yulong Li, Michael R Bruchas, Nephi Stella

Open access · greenAbstract read
In one paragraph

Article in Cannabis and cannabinoid research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Unraveling Endocannabinoid Signaling Pathways in Cisplatin-Induced Ototoxicity.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Genetically Encoded CBInternational journal of molecular sciences · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. P2XBritish journal of pharmacology · 2024
    Article
  14. Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Simar SinghDepartment of Pharmacology, Pain, and Emotion, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-5785-8292
Dennis SarrozaDepartment of Pharmacology, Pain, and Emotion, School of Medicine, University of Washington, Seattle, Washington, USA.
Anthony EnglishDepartment of Pharmacology, Pain, and Emotion, School of Medicine, University of Washington, Seattle, Washington, USA.
Maya McGroryDepartment of Pharmacology, Pain, and Emotion, School of Medicine, University of Washington, Seattle, Washington, USA.
Ao DongPeking University School of Life Sciences, PKU-IDG/McGovern Institute for Brain Research, Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.ORCID 0000-0002-2821-9528
Larry ZweifelDepartment of Pharmacology, Pain, and Emotion, School of Medicine, University of Washington, Seattle, Washington, USA.
Benjamin B LandDepartment of Pharmacology, Pain, and Emotion, School of Medicine, University of Washington, Seattle, Washington, USA.
Yulong LiPeking University School of Life Sciences, PKU-IDG/McGovern Institute for Brain Research, Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Michael R BruchasDepartment of Pharmacology, Pain, and Emotion, School of Medicine, University of Washington, Seattle, Washington, USA.
Nephi StellaDepartment of Pharmacology, Pain, and Emotion, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-4780-8360
University of Washington · USPeking University · CN

Funding

University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Charles Chavkin · 2019 to 2026
$13.0M
Differential control of 2-AG’s activity at CB1R by ABHD6 and MAGLR21DA056816 · NIDA · UNIVERSITY OF WASHINGTON · PI STELLA, NEPHI · 2023 to 2024
$428k
Molecular mechanism of ABHD6 enzymatic activity in neuronsR21NS118130 · NINDS · UNIVERSITY OF WASHINGTON · PI STELLA, NEPHI · 2020 to 2020
$428k
Dissecting PFC Endocannabinoid-THC -regulated circuits in movement behaviorF31DA055448 · NIDA · UNIVERSITY OF WASHINGTON · PI ENGLISH, ANTHONY EDWARD · 2022 to 2024
$131k
NIDA NIH HHS F31 DA055448NIDA NIH HHS P30 DA048736NIDA NIH HHS R21 DA056816NINDS NIH HHS R21 NS118130
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Arachidonic AcidsEndocannabinoidsGlyceridesReceptor, Cannabinoid, CB1Cannabinoid Receptor AgonistsHEK293 CellsHumansPolyunsaturated AlkamidesanandamideArachidonic AcidsCannabinoid Receptor AgonistsEndocannabinoidsGlyceridesglyceryl 2-arachidonatePolyunsaturated AlkamidesReceptor, Cannabinoid, CB1CB1endocannabinoidspharmacologyphytocannabinoids

Identifiers

PMID38064488
PMCPMC11535446
OpenAlexW4389475180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.